P435-0617 Screening compound: 2-(2-fluorophenyl)-1-{4-[5-methyl-4-(morpholine-4-carbonyl)-1,3-oxazol-2-yl]piperidin-1-yl}ethan-1-one

P435-0617 Screening compound: 2-(2-fluorophenyl)-1-{4-[5-methyl-4-(morpholine-4-carbonyl)-1,3-oxazol-2-yl]piperidin-1-yl}ethan-1-one
P435-0617 Screening compound: 2-(2-fluorophenyl)-1-{4-[5-methyl-4-(morpholine-4-carbonyl)-1,3-oxazol-2-yl]piperidin-1-yl}ethan-1-one alternative view

Chemical Structure Depiction of ChemDiv screening compound P435-0617
2-(2-fluorophenyl)-1-{4-[5-methyl-4-(morpholine-4-carbonyl)-1,3-oxazol-2-yl]piperidin-1-yl}ethan-1-one

Available from 1 mg

Formats:

  • Glass Vials (4ml Glass Vials VWR #97047-678)
  • 96-tube racks (Matrix #4247 96-well 1.4ml sealed with capmats, empty cols 1 & 12, 100uL of 10mM)

Shiptime: 1 week worldwide delivery in most cases

Compound Identifiers

ChemDiv Compound ID

P435-0617

Molecular Formula

C22H26FN3O4 (C22 H26 FN3 O4)

Compound Name

2-(2-fluorophenyl)-1-{4-[5-methyl-4-(morpholine-4-carbonyl)-1,3-oxazol-2-yl]piperidin-1-yl}ethan-1-one

IUPAC name

2-(2-fluorophenyl)-1-{4-[5-methyl-4-(morpholine-4-carbonyl)-13-oxazol-2-yl]piperidin-1-yl}ethan-1-one

SMILES

Cc1c(C(N2CCOCC2)=O)nc(C(CC2)CCN2C(Cc(cccc2)c2F)=O)o1

InChI

InChI=1S/C22H26FN3O4/c1-15-20(22(28)26-10-12-29-13-11-26)24-21(30-15)16-6-8-25(9-7-16)19(27)14-17-4-2-3-5-18(17)23/h2-5,16H,6-14H2,1H3

InChI Key

JOOWVVYJXSBDJL-UHFFFAOYSA-N

MDL Number (MFCD)

MFCD27575204

Chemical and Physical Properties

Saltdata

n/a

Molecular Weight

415.46

Hydrogen Bond Acceptors Count

7.00

Hydrogen Bond Donors Count

0.00

Rotatable Bond Count

6.00

Number of Nitrogen and Oxygen Atoms

7

Partition Coefficient, logP

2.155

Distribution Coefficient, logD

2.155

Water Solubility, LogSw

-2.21

Polar Surface Area

58.543

Acid Dissociation Constant (pKa)

18.21

Base Dissociation Constant (pKb)

-0.88

Number of Chiral Centers

0.00

Percent sp3 carbon bonding

50.00

P435-0617 in Drug Discovery

Included in Screening Libraries

PI3K-Targeted Library (17255 compounds)

PPI Helix Turn 3D-Mimetics Library (71298 compounds)

Protein-Protein Interaction Library (218420 compounds)

Alpha-Helix Mimetics Library (25899 compounds)

Beyond the Flatland Library sp3 enriched (92988 compounds)

Included in 1.7M Stock Database

Therapeutical areas:
  • Cancer
  • Digestive system
  • Respiratory tract
  • Otorhinolaryngologic
  • Male
  • Female
  • Hemic and lymphatic
  • Skin
Targets:
  • Kinases
Mechanism of action:
  • PPI modulators
  • PPI modulators
  • PPI modulators
Structure:
  • Mimetics
  • Mimetics
  • Cyclic compounds

References: we are preparing a list of scientific research reports with P435-0617 chemical compound. It will be published here after verification.

Frequently Asked Questions

How to purchase chemical compound P435-0617?
Check Price and Availability of P435-0617, then you can add required amount to the Shopping Cart. In the Shopping Cart you can again refine your selection. Once you are sure that it’s exactly what you want you can move forward with the Checkout (to pay online by credit card, or via PayPal), or Request a Quote.
What is the minimum amount of P435-0617 you sell to drug discovery company or institution?
Available from 1 mg in Glass Vials or 96-tube racks.
Delivery options for P435-0617
ChemDiv sends parcels with Express services (UPS, WC).
  • 1–2 days for small orders
  • 2–4 weeks for large selections
Delivery formats for P435-0617
  • 0.5–50 mg of dry powder sample in single glass vials, custom vials
  • DMSO solutions frozen 10μl–250μl@10mM (96 and 384 format)

Custom synthesis of P435-0617 available by request